NCT04640025 A Rollover Study to Provide Continued Treatment for Participants Previously Enrolled in Studies of Itacitinib Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04431479 Predicting the Quality of Response to Specific Treatments in Patients With cGVHD, PQRST Study Status RECRUITING Phase N/A
NCT04212416 Leflunomide in Treating Patients With Steroid Dependent Chronic Graft Versus Host Disease Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT03839069 Minor Salivary Gland Transplantation for Cicatrizing Conjunctivitis Status UNKNOWN Phase NA
NCT03790332 Phase 1/2 Dose Finding and Safety Study of Ibrutinib in Pediatric Subjects With Chronic Graft Versus Host Disease (cGVHD) Status COMPLETED Phase PHASE1/PHASE2
NCT03483675 Discontinuation or Continuation of Immunosuppressive Therapy in Participants With Chronic Graft Versus Host Disease Status COMPLETED Phase PHASE2
NCT03007238 Extracorporeal Photopheresis and Low Dose Aldesleukin in Treating Patients With Steroid Refractory Chronic Graft-Versus-Host Disease Status COMPLETED Phase PHASE2
NCT02959944 Ibrutinib in Combination With Corticosteroids vs Placebo in Combination With Corticosteroids in Participants With New Onset Chronic Graft Versus Host Disease (cGVHD) Status COMPLETED Phase PHASE3
NCT02749084 Multiple Donor Treg DLI for Severe Refractory Chronic GVHD Status COMPLETED Phase PHASE1/PHASE2
NCT02701634 Efficacy and Tolerability of Entospletinib in Combination With Systemic Corticosteroids as First-Line Therapy in Adults With Chronic Graft Versus Host Disease (cGVHD) Status TERMINATED Phase PHASE2
NCT02513498 Ixazomib Citrate in Treating Patients With Chronic Graft-versus-Host Disease Status COMPLETED Phase PHASE2
NCT02491359 Carfilzomib in Treating Patients With Chronic Graft-Versus-Host Disease Status COMPLETED Phase PHASE2
NCT02461134 Clinical Study to Investigate the Biological Activity, Safety, Tolerability, and Pharmacokinetics of Ponesimod in Subjects With Symptomatic Chronic GVHD Status TERMINATED Phase PHASE2
NCT02352064 Evaluation of the Diagnostic Value of PET (18F-FDG) in Chronic Graft Versus Host Disease (cGVH) Status UNKNOWN Phase NA
NCT02337517 Vismodegib in Treating Patients With Steroid-Refractory Chronic Graft-Versus-Host Disease Status TERMINATED Phase PHASE2
NCT01964625 Positron Emission Tomography - Computed Tomography (PET-CT) Scanning in Chronic Graft Versus Host Disease (cGvHD) Status TERMINATED Phase NA
NCT01954979 Abatacept to Treat Steroid Refractory Chronic Graft Versus Host Disease (cGVHD) Status COMPLETED Phase PHASE1
NCT01937468 Trial of Regulatory T-cells Plus Low-Dose Interleukin-2 for Steroid-Refractory Chronic Graft-versus-Host-Disease Status ACTIVE_NOT_RECRUITING Phase PHASE1